Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative Α-Syn and Clearing ROS in Parkinson's Disease.

Meina He,Xiangming Zhang,Xia Ran,Yan Zhang,Xiaoran Nie,Bo Xiao,Li Lei,Suzhen Zhai,Jinming Zhu,Jingjing Zhang,Rong Li,Zuoji Liu,Yuping Zhu,Zhijun Dai,Zhixu He,Jian Feng,Chunlin Zhang
DOI: https://doi.org/10.1002/adma.202404576
IF: 29.4
2024-01-01
Advanced Materials
Abstract:Although evidence indicates that the abnormal accumulation of alpha-synuclein (alpha-syn) in dopamine neurons of the substantia nigra is the main pathological feature of Parkinson's disease (PD), no compounds that have both alpha-syn antiaggregation and alpha-syn degradation functions have been successful in treating the disease in the clinic. Here, it is shown that black phosphorus nanosheets (BPNSs) interact directly with alpha-syn fibrils to trigger their disaggregation for PD treatment. Moreover, BPNSs have a specific affinity for alpha-syn through van der Waals forces. And BPNSs are found to activate autophagy to maintain alpha-syn homeostasis, improve mitochondrial dysfunction, reduce reactive oxygen species levels, and rescue neuronal death and synaptic loss in PC12 cells. It is also observed that BPNSs penetrate the blood-brain barrier and protect against dopamine neuron loss, alleviating behavioral disorders in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced mouse model and hA53T alpha-syn transgenic mice. Together, the study reveals that BPNSs have the potential as a novel integrated nanomedicine for clinical diagnosis and treatment of neurological diseases.
What problem does this paper attempt to address?